[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.173.184. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 363
Citations 0
Invited Commentary
January 2016

Survival After Lymphadenectomy in Patients With Esophageal CancerA Controversial Issue

Author Affiliations
  • 1Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois
JAMA Surg. 2016;151(1):40. doi:10.1001/jamasurg.2015.2599

A lot of progress has been made in the last 20 years in the treatment of esophageal cancer, mostly owing to the introduction of neoadjuvant therapy and to a decrease in morbidity and mortality achieved by expert surgeons who work in high-volume centers. However, stage by stage, the prognosis of this cancer has not changed much over the years, and surgery is still the mainstay of treatment. To improve survival, surgeons have been exploring the role of a more extensive resection and, in particular, the role of a more extensive lymphadenectomy. This technical aspect remains today one of the most controversial issues in the treatment of esophageal cancer. The basic questions are still the same: does an extended lymphadenectomy increase survival? And in the absence of a definitive answer, is the increased morbidity and mortality justified?

First Page Preview View Large
First page PDF preview
First page PDF preview
×